|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 38/37 | (2006.01) |
| C07K 17/08 | (2006.01) |
| (11) | Number of the document | 1824988 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05849392.5 |
| Date of filing the European patent application | 2005-11-14 | |
| (97) | Date of publication of the European application | 2007-08-29 |
| (45) | Date of publication and mention of the grant of the patent | 2017-04-19 |
| (46) | Date of publication of the claims translation | 2017-10-25 |
| (86) | Number | PCT/US2005/041205 |
| Date | 2005-11-14 |
| (87) | Number | WO 2006/053299 |
| Date | 2006-05-18 |
| (30) | Number | Date | Country code |
| 627277 P | 2004-11-12 | US |
| (72) |
Pan, Clark Q., US
Murphy, John E., US
Mei, Baisong, US
Strauss, Jonathan S., US
Tjandra, Hendri, US
Chen, Jianmin, US
Barnett, Thomas, US
Tang, Liang, US
Wang, Deqian, US
|
| (73) |
Bayer HealthCare LLC,
100 Bayer Boulevard PO Box 915, Whippany, NJ 07981,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Nukreipta į užduotą saitą FVIII modifikacija |
| SITE-DIRECTED MODIFICATION OF FVIII |
| Payment date | Validity (years) | Amount | |
| 2024-10-21 | 347.00 EUR |